Desuden bør Udvalget for Avancerede Terapier høres i forbindelse med vurdering af andre lægemidler, der kræver særlig sagkundskab inden for udvalgets kompetenceområde. ###>In addition, the Committee for Advanced Therapies should be consulted for the evaluation of any other medicinal product which requires specific expertise falling within its area of competence.